Literature DB >> 1333807

Glycogen synthase kinase-3: functions in oncogenesis and development.

S E Plyte1, K Hughes, E Nikolakaki, B J Pulverer, J R Woodgett.   

Abstract

Study of GSK-3 had an inauspicious beginning rooted in intermediary metabolism. However, owing to the fortuitous convergence of several disparate areas of biology, the enzyme now offers unique opportunities for study of the control of a variety cellular processes. While at first sight a role in transcriptional regulation appears unlikely for a protein first identified as acting on glycogen synthase, it is even more surprising that the same protein should be functionally interchangeable with a fruit fly homeotic gene. Such understandable scepticism, however, is based on teleological bias. Glycogen synthase is a critical enzyme regulating glucose storage. The c-Jun oncoprotein may have the potential to transform cells but this does not excuse it from similar mechanisms of control to glycogen synthase. Likewise, homeotic genes play a crucial role in setting up the body plan of an embryo but must also be subject to control. The main difference is that when such control is lost, the result is rather graphic. It is, therefore, only to be expected that regulatory protein kinases will surface in superficially quite unrelated areas and that many of their targets will be 'housekeeping' proteins. Perhaps the most difficult aspect of protein phosphorylation research is the linking of physiological substrates with particular protein kinases, hence reconstructing pathways. No matter how compelling in vitro data appear, there must be demonstration that the protein is targeted by the specific protein kinase in cells, an extremely difficult process. Most progress in this respect has been made using genetic analysis in lower organisms, especially yeast. Here another problem arises: demonstration of biochemical linkages underlying genetic interactions which requires function to be ascribed to genes identified by a gross effect. The challenge is to co-ordinate these two approaches, a strategy currently being employed to further unravel the biological role of GSK-3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333807     DOI: 10.1016/0304-419x(92)90012-n

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  106 in total

1.  Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells.

Authors:  B S Li; W Ma; L Zhang; J L Barker; D A Stenger; H C Pant
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

2.  Wound-induced expression and activation of WIG, a novel glycogen synthase kinase 3.

Authors:  C Jonak; D Beisteiner; J Beyerly; H Hirt
Journal:  Plant Cell       Date:  2000-08       Impact factor: 11.277

3.  Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors:  Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

4.  Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action.

Authors:  H Eldar-Finkelman; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

Authors:  M Li; X Wang; M K Meintzer; T Laessig; M J Birnbaum; K A Heidenreich
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.

Authors:  Kylene Kehn-Hall; Irene Guendel; Lawrence Carpio; Leandros Skaltsounis; Laurent Meijer; Lena Al-Harthi; Joseph P Steiner; Avindra Nath; Olaf Kutsch; Fatah Kashanchi
Journal:  Virology       Date:  2011-04-22       Impact factor: 3.616

7.  Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3.

Authors:  Kayode K Ojo; Tracy L Arakaki; Alberto J Napuli; Krishna K Inampudi; Katelyn R Keyloun; Li Zhang; Wim G J Hol; Christophe L M J Verlinde; Ethan A Merritt; Wesley C Van Voorhis
Journal:  Mol Biochem Parasitol       Date:  2010-12-30       Impact factor: 1.759

8.  First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.

Authors:  Isela García; Yagamare Fall; Generosa Gómez; Humberto González-Díaz
Journal:  Mol Divers       Date:  2010-10-08       Impact factor: 2.943

9.  Glycogen synthase kinase 3beta interaction protein functions as an A-kinase anchoring protein.

Authors:  Christian Hundsrucker; Philipp Skroblin; Frank Christian; Hans-Michael Zenn; Viola Popara; Mangesh Joshi; Jenny Eichhorst; Burkhard Wiesner; Friedrich W Herberg; Bernd Reif; Walter Rosenthal; Enno Klussmann
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

10.  AtSKtheta, a plant homologue of SGG/GSK-3 marks developing tissues in Arabidopsis thaliana.

Authors:  R Tavares; J Vidal; A van Lammeren; M Kreis
Journal:  Plant Mol Biol       Date:  2002-09       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.